том 40 издание 7 страницы 1211-1220

Stereoselective Crystallization as a Basis for Single-Enantiomer Drug Production

Тип публикацииJournal Article
Дата публикации2017-05-31
scimago Q2
wos Q3
БС2
SJR0.374
CiteScore3.6
Impact factor1.6
ISSN09307516, 15214125
General Chemistry
General Chemical Engineering
Industrial and Manufacturing Engineering
Краткое описание
In the XXI century, single enantiomeric chiral active pharmaceutical ingredients (APIs) prevail among new drugs. Their preparation is made easier by using direct methods for the separation of racemates. This review summarises the history of the issue, provides information about new and updated methods of conglomerate identification and practical implementation options for direct resolutions. Examples are given of the use of direct methods for obtaining enantiopure APIs by the resolution of their racemic synthetic precursors, using a slight modification of the target product and finally by direct resolution of the racemic chiral drugs as such.
Найдено 
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

1
2
3
4
5
Chemical Engineering and Technology
5 публикаций, 18.52%
Crystal Growth and Design
5 публикаций, 18.52%
Symmetry
3 публикации, 11.11%
Acta Crystallographica Section E: Crystallographic Communications
2 публикации, 7.41%
CrystEngComm
2 публикации, 7.41%
Crystals
1 публикация, 3.7%
Applied Sciences (Switzerland)
1 публикация, 3.7%
Mendeleev Communications
1 публикация, 3.7%
Tetrahedron Asymmetry
1 публикация, 3.7%
Journal of Molecular Structure
1 публикация, 3.7%
ACS Omega
1 публикация, 3.7%
Russian Journal of Organic Chemistry
1 публикация, 3.7%
Separation and Purification Technology
1 публикация, 3.7%
Digital Chemical Engineering
1 публикация, 3.7%
Carbohydrate Research
1 публикация, 3.7%
1
2
3
4
5

Издатели

1
2
3
4
5
6
American Chemical Society (ACS)
6 публикаций, 22.22%
MDPI
5 публикаций, 18.52%
Elsevier
5 публикаций, 18.52%
Wiley
5 публикаций, 18.52%
International Union of Crystallography (IUCr)
2 публикации, 7.41%
Royal Society of Chemistry (RSC)
2 публикации, 7.41%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 3.7%
Pleiades Publishing
1 публикация, 3.7%
1
2
3
4
5
6
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
27
Поделиться
Цитировать
ГОСТ |
Цитировать
Bredikhin A. A., Bredikhina Z. A. Stereoselective Crystallization as a Basis for Single-Enantiomer Drug Production // Chemical Engineering and Technology. 2017. Vol. 40. No. 7. pp. 1211-1220.
ГОСТ со всеми авторами (до 50) Скопировать
Bredikhin A. A., Bredikhina Z. A. Stereoselective Crystallization as a Basis for Single-Enantiomer Drug Production // Chemical Engineering and Technology. 2017. Vol. 40. No. 7. pp. 1211-1220.
RIS |
Цитировать
TY - JOUR
DO - 10.1002/ceat.201600649
UR - https://doi.org/10.1002/ceat.201600649
TI - Stereoselective Crystallization as a Basis for Single-Enantiomer Drug Production
T2 - Chemical Engineering and Technology
AU - Bredikhin, Alexander A.
AU - Bredikhina, Zemfira A.
PY - 2017
DA - 2017/05/31
PB - Wiley
SP - 1211-1220
IS - 7
VL - 40
SN - 0930-7516
SN - 1521-4125
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2017_Bredikhin,
author = {Alexander A. Bredikhin and Zemfira A. Bredikhina},
title = {Stereoselective Crystallization as a Basis for Single-Enantiomer Drug Production},
journal = {Chemical Engineering and Technology},
year = {2017},
volume = {40},
publisher = {Wiley},
month = {may},
url = {https://doi.org/10.1002/ceat.201600649},
number = {7},
pages = {1211--1220},
doi = {10.1002/ceat.201600649}
}
MLA
Цитировать
Bredikhin, Alexander A., and Zemfira A. Bredikhina. “Stereoselective Crystallization as a Basis for Single-Enantiomer Drug Production.” Chemical Engineering and Technology, vol. 40, no. 7, May. 2017, pp. 1211-1220. https://doi.org/10.1002/ceat.201600649.